Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 2 3

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Breast 1

Conditions

Brain Neoplasms 2Neoplasm Metastasis 1Glioblastoma 1Breast Neoplasms 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Neuropsychological Tests × Clear all
NCT05503251 2025-12-24

Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases

Ohio State University Comprehensive Cancer Center

Phase 2 Active not recruiting
110 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT01854554 2024-01-02

Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)

M.D. Anderson Cancer Center

Phase 2 Completed
90 enrolled 11 charts
CNS

Brain Neoplasms, Glioblastoma

NCT01332916 2014-04-25

CANMEM

Centre Francois Baclesse

Phase 2 Terminated
60 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡